Sankala Group’s CME Group CME Stock Holding History

Sankala Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$164K	Buy	549 +126	+30%	+$37.4K	0.13%	136
2025 Q4	$135K	Buy	+423	New	+$115K	0.11%	152

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sankala Group's CME Position: Q1 2026 in Review

Sankala Group increased its CME Group (CME) stake by 30% in Q1 2026, buying an estimated $37.4K and bringing the position to 549 shares worth $164K. The position accounts for 0.13% of the portfolio, ranked #136.

Sankala Group first reported a position in CME in Q4 2025 and has held it in 2 quarters since. 1,794 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Sankala Group held 549 shares of CME Group worth $164K as of Q1 2026.
Sankala Group bought 126 CME Group shares in Q1 2026, an estimated $37.4K.
CME Group made up 0.13% of Sankala Group's portfolio in Q1 2026, its #136 holding.
Sankala Group first reported a position in CME Group in Q4 2025 and has held it in 2 quarters since.
1,794 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.